Our data suggest that pexophagy was induced in the CF group, as we demonstrated a mild increase in p62 and a clear increase in LAMP2 expression, with no difference in Pex5 and NBR1 expression in the CF-treated group compared with those in the CTL group. The gene discussed is PEX5; the disease is cystic fibrosis.